EFFECTIVENESS AND TOLERABILITY OF LOW-DOSE CYCLOPHOSPHAMIDE AND LOW-DOSE INTRAVENOUS INTERLEUKIN-2 DISSEMINATED MELANOMA

被引：216

作者：

MITCHELL, MS

KEMPF, RA

HAREL, W

SHAU, H

BOSWELL, WD

LIND, S

BRADLEY, EC

机构：

[1] UNIV SO CALIF,SCH MED,DEPT MED,LOS ANGELES,CA 90033

[2] UNIV SO CALIF,SCH MED,DEPT MICROBIOL,LOS ANGELES,CA 90033

[3] UNIV SO CALIF,SCH MED,DEPT RADIOL,LOS ANGELES,CA 90033

[4] CETUS CORP,EMERYVILLE,CA 94608

来源：

关键词：

D O I：

10.1200/JCO.1988.6.3.409

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：409 / 424

页数：16

共 22 条

[1] BERD D, 1984, CANCER RES, V44, P1275
[2] BERD D, 1984, CANCER RES, V44, P5439
[3] AUGMENTATION OF THE ANTI-TUMOR THERAPEUTIC EFFICACY OF LONG-TERM CULTURED LYMPHOCYTES-T BY INVIVO ADMINISTRATION OF PURIFIED INTERLEUKIN-2
CHEEVER, MA
GREENBERG, PD
FEFER, A
GILLIS, S
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (04) : 968 - 980
[4] CUMMINGS FJ, 1986, MED ONCOLOGY, P650
[5] GILLIS S, 1978, J IMMUNOL, V120, P2027
[6] LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON - LYSIS OF NATURAL KILLER-RESISTANT FRESH SOLID TUMOR-CELLS BY INTERLEUKIN 2-ACTIVATED AUTOLOGOUS HUMAN PERIPHERAL-BLOOD LYMPHOCYTES
GRIMM, EA
MAZUMDER, A
ZHANG, HZ
ROSENBERG, SA
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (06) : 1823 - 1841
[7] KOLITZ J E, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P235
[8] HIGH-DOSE RECOMBINANT INTERLEUKIN-2 IN THE TREATMENT OF PATIENTS WITH DISSEMINATED CANCER - RESPONSES, TREATMENT-RELATED MORBIDITY, AND HISTOLOGIC-FINDINGS
LOTZE, MT
CHANG, AE
SEIPP, CA
SIMPSON, C
VETTO, JT
ROSENBERG, SA
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (22): : 3117 - 3124
[9] LOTZE MT, 1985, J IMMUNOL, V135, P1865
[10] Menck H R, 1985, Natl Cancer Inst Monogr, V69, P105